EAM Investors’s Antares Pharma, Inc. ATRS Stock Holding History

EAM Investors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-732,975	Closed	-$3.44M	–	312
2019 Q4	$3.44M	Buy	+732,975	New	+$3M	0.76%	23
2017 Q3	–	Sell	-251,619	Closed	-$810K	–	366
2017 Q2	$810K	Hold	251,619	–	–	0.13%	221
2017 Q1	$715K	Buy	+251,619	New	+$605K	0.11%	242

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

EAM Investors's ATRS Position: Q1 2020 in Review

EAM Investors sold out of Antares Pharma, Inc. (ATRS) in Q1 2020, closing a stake of 732,975 shares — an estimated $3.44M sold.

EAM Investors first reported a position in ATRS in Q1 2017 and held it in 3 quarters. The position peaked at $3.44M in Q4 2019. 154 funds tracked by Wall St. Rank hold ATRS as of Q1 2020.

EAM Investors reported no remaining Antares Pharma, Inc. position as of Q1 2020 after selling out during the quarter.
EAM Investors sold 732,975 Antares Pharma, Inc. shares in Q1 2020, an estimated $3.44M.
EAM Investors first reported a position in Antares Pharma, Inc. in Q1 2017 and held it in 3 quarters.
EAM Investors's Antares Pharma, Inc. position peaked at $3.44M in Q4 2019.
154 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2020.

Based on EAM Investors's 13F filing for Q1 2020, filed 13 May 2020.